Additionally, the expression of downstream targets, including cyclin D1 and P70, was downregulated by SR-B1 silencing.<h4>Conclusion</h4>SR-B1 contributes to the enhanced proliferation and migration of breast cancer cells, likely through activation of the PI3K/AKT signaling pathway. Here, AKT1 is linked to breast carcinoma.